Incyte (INCY) Change in Receivables (2010 - 2026)

Incyte (INCY) posted Change in Receivables of $27.0 million for Q1 2026, down 78.97% on a QoQ basis from $128.5 million in Q4 2025, and up 187.31% year-over-year from $9.4 million in Q1 2025.

Incyte (INCY) Change in Receivables (2010 - 2026) Analysis & Trends

Incyte's Change in Receivables history runs 17 years deep, the most recent figure standing at $27.0 million for Q1 2026.

  • Quarterly Change in Receivables rose 187.31% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $228.8 million (up 190.81% YoY) and the FY2025 annual result came in at $170.8 million, up 53.04% from the prior year.
  • Change in Receivables was $27.0 million for Q1 2026 at Incyte, down from $128.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $128.5 million in Q4 2025 and bottomed at -$64.8 million in Q3 2022.
  • A 5-year average of $25.7 million and a median of $19.4 million in 2024 frame the typical range for Change in Receivables.
  • Peak annual rise in Change in Receivables reached 412.37% in 2025, while the deepest fall reached 1672.12% in 2025.
  • Incyte's Change in Receivables stood at $26.7 million in 2022, then soared by 223.31% to $86.3 million in 2023, then climbed by 12.05% to $96.7 million in 2024, then soared by 32.89% to $128.5 million in 2025, then slumped by 78.97% to $27.0 million in 2026.
  • Business Quant data shows INCY's Change in Receivables at $27.0 million in Q1 2026, $128.5 million in Q4 2025, and $53.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 75.30 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.84 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 27.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.03 Mn
Mar 31, 2026 27.03 Mn
Dec 31, 2025 128.50 Mn
Dec 31, 2025 128.50 Mn
Sep 30, 2025 53.00 Mn
Sep 30, 2025 53.00 Mn
Jun 30, 2025 20.23 Mn
Jun 30, 2025 20.23 Mn
Mar 31, 2025 -30.96 Mn
Mar 31, 2025 -30.96 Mn
Dec 31, 2024 96.69 Mn
Dec 31, 2024 96.69 Mn
Sep 30, 2024 19.40 Mn
Sep 30, 2024 19.40 Mn
Jun 30, 2024 -6.48 Mn
Jun 30, 2024 -6.48 Mn
Mar 31, 2024 1.97 Mn
Mar 31, 2024 1.97 Mn
Dec 31, 2023 86.29 Mn
Dec 31, 2023 86.29 Mn